Resultados de la búsqueda 801-810 of 1942 for decrease distributed program

  1. Neurología - Ensayos clínicos

    The purpose of this study is to measure changes in autonomic nervous system functioning to show the impact of down-regulation techniques under cognitive stress.

  2. Encefalitis - Médicos y departamentos - Mayo Clinic

    Mayo Clinic tiene uno de los centros médicos más grandes y experimentados en los Estados Unidos, con sedes en Arizona, Florida y Minnesota. El personal, que ...

  3. Neurología - Ensayos clínicos

    ... decline (e.g., Mueller et al, 2018). We propose to add a series of in-clinic language elicitation tasks that allow for automated assessment of relevant ...

  4. Ensayos clínicos - Neurología

    The overall goal of PPMI is to identify markers of disease progression for use in clinical trials of therapies to reduce progression of PD disability. PLS ...

  5. Ensayos clínicos - Neurología

    This study will determine the validity of predictive and surrogate biomarkers for the detection of Parkinson's disease and Parkinson's disease cognitive decline ...

  6. Neurología - Ensayos clínicos

    Study findings may help researchers design more programs that can improve memory, attention, and brain health in other women with breast cancer. The ...

  7. Neurocirugía - Ensayos clínicos

    Rochester, Minn., Jacksonville, Fla. To collect post-approval data comparing the safety and effectiveness of CraniSeal Dural Sealant to DuraSeal Dural Sealant.

  8. Neurología - Ensayos clínicos

    ... decline (e.g., Mueller et al, 2018). We propose to add a series of in-clinic language elicitation tasks that allow for automated assessment of relevant ...

  9. Ensayos clínicos - Neurología

    The purpose of this post-approval study is to further evaluate the long-term safety and effectiveness of Medtronic DBS therapy for epilepsy on seizure reduction ...

  10. Oncología (médica) - Ensayos clínicos

    Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...